Skip to main content

Retail Clinics

  • Max-Wellness, Humana partner on new in-home healthcare solutions service

    WOODMERE, Ohio — Health-and-wellness retailer Max-Wellness on Tuesday announced a series of initiatives that vastly will expand the reach of the upstart company.

    Among them:

  • Report: FDA warns of long-term PPI use

    SILVER SPRING, Md. — The Food and Drug Administration is warning that long-term use of a class of drugs for gastroesophageal reflux disease may decrease levels of magnesium in the body and increase the risk of such side effects as seizures and heart rhythm problems, according to published reports.

    The reports quoted the FDA as saying that in a quarter of cases of proton-pump inhibitors depleting magnesium from the body, use of magnesium supplements did not bring levels back to normal, and use of the drugs had to be stopped.

  • FDA targets unapproved cough-cold, allergy drugs with Unapproved Drugs Initiative

    SILVER SPRING, Md. — The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

    The action is part of the agency’s Unapproved Drugs Initiative, which seeks to remove from the market drugs that have not received approval. In many cases, the drugs were marketed before the FDA adopted its current regulatory standards.

  • Study: Physicians more likely to prescribe Rxs with adherence incentives

    NEW YORK — Physicians are 30% more likely to prescribe a drug that gives patients incentives to remain adherent to it than they are to prescribe a drug without such a program, according to a new survey.

    The survey of 100 doctors, sponsored by HealthPrize Technologies and conducted by pharmaceutical marketing firm HealthcarePanel.org, also found 89% of doctors were comfortable with the idea of rewarding patients for adherence, along with using education.

  • Cherokee Uniforms accepting nominations for annual Inspired Comfort Award

    LOS ANGELES — Medical scrubs provider Cherokee Uniforms has announced that it is accepting nominations through May 31 for its annual Inspired Comfort Award, which recognizes those healthcare professionals, such as registered nurses and advanced practice nurses, who go above and beyond the call of duty to make a difference for their patients and the communities they serve.

  • Sugary drinks associated with hypertension, study finds

    DALLAS — A new study published in Hypertension: Journal of the American Heart Association established a link between high blood pressure and the consumption of such beverages as soda and other sugar-sweetened drinks.

  • Cold sore treatment Xerese enters market

    HUDDINGE, Sweden — Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

    The Swedish drug maker launched Xerese (acyclovir and hydrocortisone), a topical combination product designed to treat recurrent herpes simplex labialis.

    Medivir said the U.S. market for cold sore products is $230 million, and it expected the drug to be successful, given Meda’s presence in the U.S. market.

  • Matrix Labs' gabapentin capsules get FDA OK

    PITTSBURGH — The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

    Mylan announced Monday the approval of Matrix Labs’ gabapentin capsules in the 100-mg, 300-mg and 400-mg strengths. The drug is used to treat postherpetic neuralgia, a painful complication of shingles.

    Gabapentin capsules had sales of about $300 million in 2010, according to IMS Health.

X
This ad will auto-close in 10 seconds